Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

Patients Follow-Up and Response Criteria

MF Marica Ferro
MF Milena Ferro
GM Gabriella Macchia
SC Savino Cilla
MB Milly Buwenge
AR Alessia Re
CR Carmela Romano
MB Mariangela Boccardi
VP Vincenzo Picardi
SC Silvia Cammelli
EC Eleonora Cucci
SM Samantha Mignogna
LL Liberato Di Lullo
VV Vincenzo Valentini
AM Alessio Giuseppe Morganti
FD Francesco Deodato
request Request a Protocol
ask Ask a question
Favorite

Patients were evaluated three weeks after treatment completion and then every two months with clinical examination and blood tests. A contrast-enhanced multiparametric brain MRI was performed 45 days after RT completion and then every two months. Clinical response was evaluated based on the RECIST criteria in patients with macroscopic residual disease after surgery (24). In case of suspected pseudoprogression, a 6-[18F]-L-fluoro-L-3,4-dihydroxyphenylalanine-PET/CT was performed. In case of progressive disease in the brain, patients were considered for salvage treatment on a case-by-case basis (re-operation, second-line chemotherapy or re-irradiation).

Copyright and License information:  ©2021 Ferro, Ferro, Macchia, Cilla, Buwenge, Re, Romano, Boccardi, Picardi, Cammelli, Cucci, Mignogna, Di Lullo, Valentini, Morganti and Deodato
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A